BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32234672)

  • 1. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
    Le Vée M; Bruyère A; Jouan E; Fardel O
    Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes.
    Febvre-James M; Bruyère A; Le Vée M; Fardel O
    Drug Metab Dispos; 2018 Feb; 46(2):131-140. PubMed ID: 29162613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
    Le Vee M; Gripon P; Stieger B; Fardel O
    Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
    Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
    Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.
    Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
    PLoS One; 2015; 10(3):e0121232. PubMed ID: 25803276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells.
    Bachour-El Azzi P; Sharanek A; Abdel-Razzak Z; Antherieu S; Al-Attrache H; Savary CC; Lepage S; Morel I; Labbe G; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2014 Sep; 42(9):1556-66. PubMed ID: 25002748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.
    Andrejko KM; Raj NR; Kim PK; Cereda M; Deutschman CS
    Shock; 2008 Apr; 29(4):490-6. PubMed ID: 17724432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.
    Moreau A; Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):871-878. PubMed ID: 28260174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S; Le Vee M; Jouan E; Fardel O
    J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.
    Yadav AS; Stevison F; Kosaka M; Wong S; Kenny JR; Amory JK; Isoherranen N
    Drug Metab Dispos; 2022 Jul; 50(7):1042-1052. PubMed ID: 35545255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients.
    Nakai K; Tanaka H; Hanada K; Ogata H; Suzuki F; Kumada H; Miyajima A; Ishida S; Sunouchi M; Habano W; Kamikawa Y; Kubota K; Kita J; Ozawa S; Ohno Y
    Drug Metab Dispos; 2008 Sep; 36(9):1786-93. PubMed ID: 18515332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F; Fardel O; Gripon P
    Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).
    Greupink R; Dillen L; Monshouwer M; Huisman MT; Russel FG
    Eur J Pharm Sci; 2011 Nov; 44(4):487-96. PubMed ID: 21945488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter.
    Bu P; Le Y; Zhang Y; Zhang Y; Cheng X
    J Biol Chem; 2017 Mar; 292(11):4602-4613. PubMed ID: 28154180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture.
    Badolo L; Jensen B; Säll C; Norinder U; Kallunki P; Montanari D
    Xenobiotica; 2015 Feb; 45(2):177-87. PubMed ID: 25183402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.
    Chen C; Han YH; Yang Z; Rodrigues AD
    Xenobiotica; 2011 Jun; 41(6):476-85. PubMed ID: 21381897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.